The Rhode Island Eye Institute - Medicare in Providence, RI

The Rhode Island Eye Institute is a medicare enrolled "Ophthalmology" provider in Providence, Rhode Island. Their current practice location is 150 E Manning St, Providence, Rhode Island. You can reach out to their office (for appointments etc.) via phone at (401) 272-2020.

The Rhode Island Eye Institute is licensed to practice in Rhode Island (license number MD05032) and it also participates in the medicare program. The Rhode Island Eye Institute is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1366429102.

Contact Information

The Rhode Island Eye Institute
150 E Manning St,
Providence, RI 02906-5109
(401) 272-2020
(401) 421-5979



Healthcare Provider's Profile

Full NameThe Rhode Island Eye Institute
TypeFacility
SpecialityOphthalmology
Location150 E Manning St, Providence, Rhode Island
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1366429102
  • Provider Enumeration Date: 12/22/2005
  • Last Update Date: 07/31/2012
  Medicare PECOS Information:
  • PECOS PAC ID: 9133182611
  • Enrollment ID: O20051001000056

Medical Identifiers

Medical identifiers for The Rhode Island Eye Institute such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1366429102NPI-NPPES
0012176OtherMANEIGHBORHOOD MA
603940OtherRITUFTS
0859OtherRINEIGHBORHOOD RI
189002658OtherRIMEDICARE PIN
M17477OtherMAMASS BLUE SHIELD
1760528962OtherRINPI OTHER
26587OtherRIRI BLUE SHIELD
9001520MedicaidRI

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist ODTA00377 (Rhode Island)Secondary
207W00000XOphthalmology MD05032 (Rhode Island)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. The Rhode Island Eye Institute acts as a billing entity for following providers:
Provider NameDugald Munro
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1487614251
PECOS PAC ID: 9133171887
Enrollment ID: I20050210000795

News Archive

Advisory panel recommends FDA approve new "morning after" pill

The New York Times: A Food and Drug Administration advisory panel Thursday recommended that the agency approve "a medicine that could help prevent pregnancy if taken as late as five days after unprotected sex. The pill, called ella, sprang from government labs and appears to be more effective than Plan B, a morning-after pill now available over the counter to women 18 and older that gradually loses efficacy after intercourse and can be taken at latest three days after sex.

WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing

A team of scientists from Lawrence Berkeley National Laboratory and the Scripps Research Institute has determined the crystal structure and molecular mechanisms of a key part of WRN, a protein that protects humans from premature aging and cancer.

Cadence Pharmaceuticals' IV acetaminophen NDA receives FDA Complete Response letter

Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for intravenous (IV) acetaminophen.

Slow caress or stroke may play part in creating, sustaining positive sense of self

A loving touch, characterized by a slow caress or stroke - often an instinctive gesture from a mother to a child or between partners in romantic relationships - may increase the brain's ability to construct a sense of body ownership and, in turn, play a part in creating and sustaining a healthy sense of self.

Read more Medical News

› Verified 3 days ago

Provider NameChristopher J Newton
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1952372815
PECOS PAC ID: 1951376946
Enrollment ID: I20081030000311

News Archive

Advisory panel recommends FDA approve new "morning after" pill

The New York Times: A Food and Drug Administration advisory panel Thursday recommended that the agency approve "a medicine that could help prevent pregnancy if taken as late as five days after unprotected sex. The pill, called ella, sprang from government labs and appears to be more effective than Plan B, a morning-after pill now available over the counter to women 18 and older that gradually loses efficacy after intercourse and can be taken at latest three days after sex.

WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing

A team of scientists from Lawrence Berkeley National Laboratory and the Scripps Research Institute has determined the crystal structure and molecular mechanisms of a key part of WRN, a protein that protects humans from premature aging and cancer.

Cadence Pharmaceuticals' IV acetaminophen NDA receives FDA Complete Response letter

Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for intravenous (IV) acetaminophen.

Slow caress or stroke may play part in creating, sustaining positive sense of self

A loving touch, characterized by a slow caress or stroke - often an instinctive gesture from a mother to a child or between partners in romantic relationships - may increase the brain's ability to construct a sense of body ownership and, in turn, play a part in creating and sustaining a healthy sense of self.

Read more Medical News

› Verified 3 days ago

Provider NameGaurav Gupta
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1366559114
PECOS PAC ID: 1850392697
Enrollment ID: I20091208000539

News Archive

Advisory panel recommends FDA approve new "morning after" pill

The New York Times: A Food and Drug Administration advisory panel Thursday recommended that the agency approve "a medicine that could help prevent pregnancy if taken as late as five days after unprotected sex. The pill, called ella, sprang from government labs and appears to be more effective than Plan B, a morning-after pill now available over the counter to women 18 and older that gradually loses efficacy after intercourse and can be taken at latest three days after sex.

WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing

A team of scientists from Lawrence Berkeley National Laboratory and the Scripps Research Institute has determined the crystal structure and molecular mechanisms of a key part of WRN, a protein that protects humans from premature aging and cancer.

Cadence Pharmaceuticals' IV acetaminophen NDA receives FDA Complete Response letter

Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for intravenous (IV) acetaminophen.

Slow caress or stroke may play part in creating, sustaining positive sense of self

A loving touch, characterized by a slow caress or stroke - often an instinctive gesture from a mother to a child or between partners in romantic relationships - may increase the brain's ability to construct a sense of body ownership and, in turn, play a part in creating and sustaining a healthy sense of self.

Read more Medical News

› Verified 3 days ago

Provider NameElliot M Perlman
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1770560500
PECOS PAC ID: 2567425044
Enrollment ID: I20100616000188

News Archive

Advisory panel recommends FDA approve new "morning after" pill

The New York Times: A Food and Drug Administration advisory panel Thursday recommended that the agency approve "a medicine that could help prevent pregnancy if taken as late as five days after unprotected sex. The pill, called ella, sprang from government labs and appears to be more effective than Plan B, a morning-after pill now available over the counter to women 18 and older that gradually loses efficacy after intercourse and can be taken at latest three days after sex.

WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing

A team of scientists from Lawrence Berkeley National Laboratory and the Scripps Research Institute has determined the crystal structure and molecular mechanisms of a key part of WRN, a protein that protects humans from premature aging and cancer.

Cadence Pharmaceuticals' IV acetaminophen NDA receives FDA Complete Response letter

Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for intravenous (IV) acetaminophen.

Slow caress or stroke may play part in creating, sustaining positive sense of self

A loving touch, characterized by a slow caress or stroke - often an instinctive gesture from a mother to a child or between partners in romantic relationships - may increase the brain's ability to construct a sense of body ownership and, in turn, play a part in creating and sustaining a healthy sense of self.

Read more Medical News

› Verified 3 days ago

Provider NameDurga Strohl Larkin
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1063466324
PECOS PAC ID: 2961533997
Enrollment ID: I20100708000250

News Archive

Advisory panel recommends FDA approve new "morning after" pill

The New York Times: A Food and Drug Administration advisory panel Thursday recommended that the agency approve "a medicine that could help prevent pregnancy if taken as late as five days after unprotected sex. The pill, called ella, sprang from government labs and appears to be more effective than Plan B, a morning-after pill now available over the counter to women 18 and older that gradually loses efficacy after intercourse and can be taken at latest three days after sex.

WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing

A team of scientists from Lawrence Berkeley National Laboratory and the Scripps Research Institute has determined the crystal structure and molecular mechanisms of a key part of WRN, a protein that protects humans from premature aging and cancer.

Cadence Pharmaceuticals' IV acetaminophen NDA receives FDA Complete Response letter

Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for intravenous (IV) acetaminophen.

Slow caress or stroke may play part in creating, sustaining positive sense of self

A loving touch, characterized by a slow caress or stroke - often an instinctive gesture from a mother to a child or between partners in romantic relationships - may increase the brain's ability to construct a sense of body ownership and, in turn, play a part in creating and sustaining a healthy sense of self.

Read more Medical News

› Verified 3 days ago

Provider NameMartin Newman
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1962489799
PECOS PAC ID: 9335272137
Enrollment ID: I20100730000394

News Archive

Advisory panel recommends FDA approve new "morning after" pill

The New York Times: A Food and Drug Administration advisory panel Thursday recommended that the agency approve "a medicine that could help prevent pregnancy if taken as late as five days after unprotected sex. The pill, called ella, sprang from government labs and appears to be more effective than Plan B, a morning-after pill now available over the counter to women 18 and older that gradually loses efficacy after intercourse and can be taken at latest three days after sex.

WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing

A team of scientists from Lawrence Berkeley National Laboratory and the Scripps Research Institute has determined the crystal structure and molecular mechanisms of a key part of WRN, a protein that protects humans from premature aging and cancer.

Cadence Pharmaceuticals' IV acetaminophen NDA receives FDA Complete Response letter

Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for intravenous (IV) acetaminophen.

Slow caress or stroke may play part in creating, sustaining positive sense of self

A loving touch, characterized by a slow caress or stroke - often an instinctive gesture from a mother to a child or between partners in romantic relationships - may increase the brain's ability to construct a sense of body ownership and, in turn, play a part in creating and sustaining a healthy sense of self.

Read more Medical News

› Verified 3 days ago

Provider NameMichael Anthony Saccucci
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1265486526
PECOS PAC ID: 0446383749
Enrollment ID: I20100808000006

News Archive

Advisory panel recommends FDA approve new "morning after" pill

The New York Times: A Food and Drug Administration advisory panel Thursday recommended that the agency approve "a medicine that could help prevent pregnancy if taken as late as five days after unprotected sex. The pill, called ella, sprang from government labs and appears to be more effective than Plan B, a morning-after pill now available over the counter to women 18 and older that gradually loses efficacy after intercourse and can be taken at latest three days after sex.

WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing

A team of scientists from Lawrence Berkeley National Laboratory and the Scripps Research Institute has determined the crystal structure and molecular mechanisms of a key part of WRN, a protein that protects humans from premature aging and cancer.

Cadence Pharmaceuticals' IV acetaminophen NDA receives FDA Complete Response letter

Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for intravenous (IV) acetaminophen.

Slow caress or stroke may play part in creating, sustaining positive sense of self

A loving touch, characterized by a slow caress or stroke - often an instinctive gesture from a mother to a child or between partners in romantic relationships - may increase the brain's ability to construct a sense of body ownership and, in turn, play a part in creating and sustaining a healthy sense of self.

Read more Medical News

› Verified 3 days ago

Provider NamePaul Zerbinopoulos
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1154375418
PECOS PAC ID: 7416081609
Enrollment ID: I20100810000165

News Archive

Advisory panel recommends FDA approve new "morning after" pill

The New York Times: A Food and Drug Administration advisory panel Thursday recommended that the agency approve "a medicine that could help prevent pregnancy if taken as late as five days after unprotected sex. The pill, called ella, sprang from government labs and appears to be more effective than Plan B, a morning-after pill now available over the counter to women 18 and older that gradually loses efficacy after intercourse and can be taken at latest three days after sex.

WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing

A team of scientists from Lawrence Berkeley National Laboratory and the Scripps Research Institute has determined the crystal structure and molecular mechanisms of a key part of WRN, a protein that protects humans from premature aging and cancer.

Cadence Pharmaceuticals' IV acetaminophen NDA receives FDA Complete Response letter

Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for intravenous (IV) acetaminophen.

Slow caress or stroke may play part in creating, sustaining positive sense of self

A loving touch, characterized by a slow caress or stroke - often an instinctive gesture from a mother to a child or between partners in romantic relationships - may increase the brain's ability to construct a sense of body ownership and, in turn, play a part in creating and sustaining a healthy sense of self.

Read more Medical News

› Verified 3 days ago

Provider NameSarah Anis
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1225276678
PECOS PAC ID: 6204986334
Enrollment ID: I20110118000243

News Archive

Advisory panel recommends FDA approve new "morning after" pill

The New York Times: A Food and Drug Administration advisory panel Thursday recommended that the agency approve "a medicine that could help prevent pregnancy if taken as late as five days after unprotected sex. The pill, called ella, sprang from government labs and appears to be more effective than Plan B, a morning-after pill now available over the counter to women 18 and older that gradually loses efficacy after intercourse and can be taken at latest three days after sex.

WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing

A team of scientists from Lawrence Berkeley National Laboratory and the Scripps Research Institute has determined the crystal structure and molecular mechanisms of a key part of WRN, a protein that protects humans from premature aging and cancer.

Cadence Pharmaceuticals' IV acetaminophen NDA receives FDA Complete Response letter

Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for intravenous (IV) acetaminophen.

Slow caress or stroke may play part in creating, sustaining positive sense of self

A loving touch, characterized by a slow caress or stroke - often an instinctive gesture from a mother to a child or between partners in romantic relationships - may increase the brain's ability to construct a sense of body ownership and, in turn, play a part in creating and sustaining a healthy sense of self.

Read more Medical News

› Verified 3 days ago

Provider NameJohn P Donahue
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1164409918
PECOS PAC ID: 8426034109
Enrollment ID: I20110921000528

News Archive

Advisory panel recommends FDA approve new "morning after" pill

The New York Times: A Food and Drug Administration advisory panel Thursday recommended that the agency approve "a medicine that could help prevent pregnancy if taken as late as five days after unprotected sex. The pill, called ella, sprang from government labs and appears to be more effective than Plan B, a morning-after pill now available over the counter to women 18 and older that gradually loses efficacy after intercourse and can be taken at latest three days after sex.

WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing

A team of scientists from Lawrence Berkeley National Laboratory and the Scripps Research Institute has determined the crystal structure and molecular mechanisms of a key part of WRN, a protein that protects humans from premature aging and cancer.

Cadence Pharmaceuticals' IV acetaminophen NDA receives FDA Complete Response letter

Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for intravenous (IV) acetaminophen.

Slow caress or stroke may play part in creating, sustaining positive sense of self

A loving touch, characterized by a slow caress or stroke - often an instinctive gesture from a mother to a child or between partners in romantic relationships - may increase the brain's ability to construct a sense of body ownership and, in turn, play a part in creating and sustaining a healthy sense of self.

Read more Medical News

› Verified 3 days ago

Provider NameLory C Snady-mccoy
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1588641328
PECOS PAC ID: 7012970593
Enrollment ID: I20120208000423

News Archive

Advisory panel recommends FDA approve new "morning after" pill

The New York Times: A Food and Drug Administration advisory panel Thursday recommended that the agency approve "a medicine that could help prevent pregnancy if taken as late as five days after unprotected sex. The pill, called ella, sprang from government labs and appears to be more effective than Plan B, a morning-after pill now available over the counter to women 18 and older that gradually loses efficacy after intercourse and can be taken at latest three days after sex.

WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing

A team of scientists from Lawrence Berkeley National Laboratory and the Scripps Research Institute has determined the crystal structure and molecular mechanisms of a key part of WRN, a protein that protects humans from premature aging and cancer.

Cadence Pharmaceuticals' IV acetaminophen NDA receives FDA Complete Response letter

Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for intravenous (IV) acetaminophen.

Slow caress or stroke may play part in creating, sustaining positive sense of self

A loving touch, characterized by a slow caress or stroke - often an instinctive gesture from a mother to a child or between partners in romantic relationships - may increase the brain's ability to construct a sense of body ownership and, in turn, play a part in creating and sustaining a healthy sense of self.

Read more Medical News

› Verified 3 days ago

Provider NameRobert L Bahr
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1548246382
PECOS PAC ID: 1759344237
Enrollment ID: I20120208000676

News Archive

Advisory panel recommends FDA approve new "morning after" pill

The New York Times: A Food and Drug Administration advisory panel Thursday recommended that the agency approve "a medicine that could help prevent pregnancy if taken as late as five days after unprotected sex. The pill, called ella, sprang from government labs and appears to be more effective than Plan B, a morning-after pill now available over the counter to women 18 and older that gradually loses efficacy after intercourse and can be taken at latest three days after sex.

WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing

A team of scientists from Lawrence Berkeley National Laboratory and the Scripps Research Institute has determined the crystal structure and molecular mechanisms of a key part of WRN, a protein that protects humans from premature aging and cancer.

Cadence Pharmaceuticals' IV acetaminophen NDA receives FDA Complete Response letter

Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for intravenous (IV) acetaminophen.

Slow caress or stroke may play part in creating, sustaining positive sense of self

A loving touch, characterized by a slow caress or stroke - often an instinctive gesture from a mother to a child or between partners in romantic relationships - may increase the brain's ability to construct a sense of body ownership and, in turn, play a part in creating and sustaining a healthy sense of self.

Read more Medical News

› Verified 3 days ago

Provider NameThomas P Lang
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1891772620
PECOS PAC ID: 6608816210
Enrollment ID: I20120208000746

News Archive

Advisory panel recommends FDA approve new "morning after" pill

The New York Times: A Food and Drug Administration advisory panel Thursday recommended that the agency approve "a medicine that could help prevent pregnancy if taken as late as five days after unprotected sex. The pill, called ella, sprang from government labs and appears to be more effective than Plan B, a morning-after pill now available over the counter to women 18 and older that gradually loses efficacy after intercourse and can be taken at latest three days after sex.

WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing

A team of scientists from Lawrence Berkeley National Laboratory and the Scripps Research Institute has determined the crystal structure and molecular mechanisms of a key part of WRN, a protein that protects humans from premature aging and cancer.

Cadence Pharmaceuticals' IV acetaminophen NDA receives FDA Complete Response letter

Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for intravenous (IV) acetaminophen.

Slow caress or stroke may play part in creating, sustaining positive sense of self

A loving touch, characterized by a slow caress or stroke - often an instinctive gesture from a mother to a child or between partners in romantic relationships - may increase the brain's ability to construct a sense of body ownership and, in turn, play a part in creating and sustaining a healthy sense of self.

Read more Medical News

› Verified 3 days ago

Provider NameLori Boivin
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1861478620
PECOS PAC ID: 1557528155
Enrollment ID: I20120209000655

News Archive

Advisory panel recommends FDA approve new "morning after" pill

The New York Times: A Food and Drug Administration advisory panel Thursday recommended that the agency approve "a medicine that could help prevent pregnancy if taken as late as five days after unprotected sex. The pill, called ella, sprang from government labs and appears to be more effective than Plan B, a morning-after pill now available over the counter to women 18 and older that gradually loses efficacy after intercourse and can be taken at latest three days after sex.

WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing

A team of scientists from Lawrence Berkeley National Laboratory and the Scripps Research Institute has determined the crystal structure and molecular mechanisms of a key part of WRN, a protein that protects humans from premature aging and cancer.

Cadence Pharmaceuticals' IV acetaminophen NDA receives FDA Complete Response letter

Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for intravenous (IV) acetaminophen.

Slow caress or stroke may play part in creating, sustaining positive sense of self

A loving touch, characterized by a slow caress or stroke - often an instinctive gesture from a mother to a child or between partners in romantic relationships - may increase the brain's ability to construct a sense of body ownership and, in turn, play a part in creating and sustaining a healthy sense of self.

Read more Medical News

› Verified 3 days ago

Provider NameRobert Jeffrey Hofmann
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1972589745
PECOS PAC ID: 5193788677
Enrollment ID: I20120508000177

News Archive

Advisory panel recommends FDA approve new "morning after" pill

The New York Times: A Food and Drug Administration advisory panel Thursday recommended that the agency approve "a medicine that could help prevent pregnancy if taken as late as five days after unprotected sex. The pill, called ella, sprang from government labs and appears to be more effective than Plan B, a morning-after pill now available over the counter to women 18 and older that gradually loses efficacy after intercourse and can be taken at latest three days after sex.

WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing

A team of scientists from Lawrence Berkeley National Laboratory and the Scripps Research Institute has determined the crystal structure and molecular mechanisms of a key part of WRN, a protein that protects humans from premature aging and cancer.

Cadence Pharmaceuticals' IV acetaminophen NDA receives FDA Complete Response letter

Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for intravenous (IV) acetaminophen.

Slow caress or stroke may play part in creating, sustaining positive sense of self

A loving touch, characterized by a slow caress or stroke - often an instinctive gesture from a mother to a child or between partners in romantic relationships - may increase the brain's ability to construct a sense of body ownership and, in turn, play a part in creating and sustaining a healthy sense of self.

Read more Medical News

› Verified 3 days ago

Provider NamePranjal Thakuria
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1285830323
PECOS PAC ID: 8022183912
Enrollment ID: I20131209000312

News Archive

Advisory panel recommends FDA approve new "morning after" pill

The New York Times: A Food and Drug Administration advisory panel Thursday recommended that the agency approve "a medicine that could help prevent pregnancy if taken as late as five days after unprotected sex. The pill, called ella, sprang from government labs and appears to be more effective than Plan B, a morning-after pill now available over the counter to women 18 and older that gradually loses efficacy after intercourse and can be taken at latest three days after sex.

WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing

A team of scientists from Lawrence Berkeley National Laboratory and the Scripps Research Institute has determined the crystal structure and molecular mechanisms of a key part of WRN, a protein that protects humans from premature aging and cancer.

Cadence Pharmaceuticals' IV acetaminophen NDA receives FDA Complete Response letter

Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for intravenous (IV) acetaminophen.

Slow caress or stroke may play part in creating, sustaining positive sense of self

A loving touch, characterized by a slow caress or stroke - often an instinctive gesture from a mother to a child or between partners in romantic relationships - may increase the brain's ability to construct a sense of body ownership and, in turn, play a part in creating and sustaining a healthy sense of self.

Read more Medical News

› Verified 3 days ago

Provider NameKelly M Schoorens
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1619329315
PECOS PAC ID: 4981961067
Enrollment ID: I20171128000386

News Archive

Advisory panel recommends FDA approve new "morning after" pill

The New York Times: A Food and Drug Administration advisory panel Thursday recommended that the agency approve "a medicine that could help prevent pregnancy if taken as late as five days after unprotected sex. The pill, called ella, sprang from government labs and appears to be more effective than Plan B, a morning-after pill now available over the counter to women 18 and older that gradually loses efficacy after intercourse and can be taken at latest three days after sex.

WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing

A team of scientists from Lawrence Berkeley National Laboratory and the Scripps Research Institute has determined the crystal structure and molecular mechanisms of a key part of WRN, a protein that protects humans from premature aging and cancer.

Cadence Pharmaceuticals' IV acetaminophen NDA receives FDA Complete Response letter

Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for intravenous (IV) acetaminophen.

Slow caress or stroke may play part in creating, sustaining positive sense of self

A loving touch, characterized by a slow caress or stroke - often an instinctive gesture from a mother to a child or between partners in romantic relationships - may increase the brain's ability to construct a sense of body ownership and, in turn, play a part in creating and sustaining a healthy sense of self.

Read more Medical News

› Verified 3 days ago

Provider NameJason Edward Karo
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1033109111
PECOS PAC ID: 1850435520
Enrollment ID: I20180403001340

News Archive

Advisory panel recommends FDA approve new "morning after" pill

The New York Times: A Food and Drug Administration advisory panel Thursday recommended that the agency approve "a medicine that could help prevent pregnancy if taken as late as five days after unprotected sex. The pill, called ella, sprang from government labs and appears to be more effective than Plan B, a morning-after pill now available over the counter to women 18 and older that gradually loses efficacy after intercourse and can be taken at latest three days after sex.

WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing

A team of scientists from Lawrence Berkeley National Laboratory and the Scripps Research Institute has determined the crystal structure and molecular mechanisms of a key part of WRN, a protein that protects humans from premature aging and cancer.

Cadence Pharmaceuticals' IV acetaminophen NDA receives FDA Complete Response letter

Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for intravenous (IV) acetaminophen.

Slow caress or stroke may play part in creating, sustaining positive sense of self

A loving touch, characterized by a slow caress or stroke - often an instinctive gesture from a mother to a child or between partners in romantic relationships - may increase the brain's ability to construct a sense of body ownership and, in turn, play a part in creating and sustaining a healthy sense of self.

Read more Medical News

› Verified 3 days ago

Provider NameElizabeth R Wassenaar
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1972025187
PECOS PAC ID: 6608123773
Enrollment ID: I20180719003468

News Archive

Advisory panel recommends FDA approve new "morning after" pill

The New York Times: A Food and Drug Administration advisory panel Thursday recommended that the agency approve "a medicine that could help prevent pregnancy if taken as late as five days after unprotected sex. The pill, called ella, sprang from government labs and appears to be more effective than Plan B, a morning-after pill now available over the counter to women 18 and older that gradually loses efficacy after intercourse and can be taken at latest three days after sex.

WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing

A team of scientists from Lawrence Berkeley National Laboratory and the Scripps Research Institute has determined the crystal structure and molecular mechanisms of a key part of WRN, a protein that protects humans from premature aging and cancer.

Cadence Pharmaceuticals' IV acetaminophen NDA receives FDA Complete Response letter

Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for intravenous (IV) acetaminophen.

Slow caress or stroke may play part in creating, sustaining positive sense of self

A loving touch, characterized by a slow caress or stroke - often an instinctive gesture from a mother to a child or between partners in romantic relationships - may increase the brain's ability to construct a sense of body ownership and, in turn, play a part in creating and sustaining a healthy sense of self.

Read more Medical News

› Verified 3 days ago

Provider NameJane C Cook
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1891108940
PECOS PAC ID: 2668699935
Enrollment ID: I20190709000877

News Archive

Advisory panel recommends FDA approve new "morning after" pill

The New York Times: A Food and Drug Administration advisory panel Thursday recommended that the agency approve "a medicine that could help prevent pregnancy if taken as late as five days after unprotected sex. The pill, called ella, sprang from government labs and appears to be more effective than Plan B, a morning-after pill now available over the counter to women 18 and older that gradually loses efficacy after intercourse and can be taken at latest three days after sex.

WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing

A team of scientists from Lawrence Berkeley National Laboratory and the Scripps Research Institute has determined the crystal structure and molecular mechanisms of a key part of WRN, a protein that protects humans from premature aging and cancer.

Cadence Pharmaceuticals' IV acetaminophen NDA receives FDA Complete Response letter

Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for intravenous (IV) acetaminophen.

Slow caress or stroke may play part in creating, sustaining positive sense of self

A loving touch, characterized by a slow caress or stroke - often an instinctive gesture from a mother to a child or between partners in romantic relationships - may increase the brain's ability to construct a sense of body ownership and, in turn, play a part in creating and sustaining a healthy sense of self.

Read more Medical News

› Verified 3 days ago

Provider NameMichael I Rothschild
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1801281225
PECOS PAC ID: 0042501678
Enrollment ID: I20210607000744

News Archive

Advisory panel recommends FDA approve new "morning after" pill

The New York Times: A Food and Drug Administration advisory panel Thursday recommended that the agency approve "a medicine that could help prevent pregnancy if taken as late as five days after unprotected sex. The pill, called ella, sprang from government labs and appears to be more effective than Plan B, a morning-after pill now available over the counter to women 18 and older that gradually loses efficacy after intercourse and can be taken at latest three days after sex.

WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing

A team of scientists from Lawrence Berkeley National Laboratory and the Scripps Research Institute has determined the crystal structure and molecular mechanisms of a key part of WRN, a protein that protects humans from premature aging and cancer.

Cadence Pharmaceuticals' IV acetaminophen NDA receives FDA Complete Response letter

Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for intravenous (IV) acetaminophen.

Slow caress or stroke may play part in creating, sustaining positive sense of self

A loving touch, characterized by a slow caress or stroke - often an instinctive gesture from a mother to a child or between partners in romantic relationships - may increase the brain's ability to construct a sense of body ownership and, in turn, play a part in creating and sustaining a healthy sense of self.

Read more Medical News

› Verified 3 days ago

Provider NameNikolas Raufi
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1851755995
PECOS PAC ID: 1052735628
Enrollment ID: I20210608002410

News Archive

Advisory panel recommends FDA approve new "morning after" pill

The New York Times: A Food and Drug Administration advisory panel Thursday recommended that the agency approve "a medicine that could help prevent pregnancy if taken as late as five days after unprotected sex. The pill, called ella, sprang from government labs and appears to be more effective than Plan B, a morning-after pill now available over the counter to women 18 and older that gradually loses efficacy after intercourse and can be taken at latest three days after sex.

WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing

A team of scientists from Lawrence Berkeley National Laboratory and the Scripps Research Institute has determined the crystal structure and molecular mechanisms of a key part of WRN, a protein that protects humans from premature aging and cancer.

Cadence Pharmaceuticals' IV acetaminophen NDA receives FDA Complete Response letter

Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for intravenous (IV) acetaminophen.

Slow caress or stroke may play part in creating, sustaining positive sense of self

A loving touch, characterized by a slow caress or stroke - often an instinctive gesture from a mother to a child or between partners in romantic relationships - may increase the brain's ability to construct a sense of body ownership and, in turn, play a part in creating and sustaining a healthy sense of self.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. The Rhode Island Eye Institute is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
The Rhode Island Eye Institute
150 E Manning St,
Providence, RI 02906-5109

Ph: (401) 272-2020
The Rhode Island Eye Institute
150 E Manning St,
Providence, RI 02906-5109

Ph: (401) 272-2020

News Archive

Advisory panel recommends FDA approve new "morning after" pill

The New York Times: A Food and Drug Administration advisory panel Thursday recommended that the agency approve "a medicine that could help prevent pregnancy if taken as late as five days after unprotected sex. The pill, called ella, sprang from government labs and appears to be more effective than Plan B, a morning-after pill now available over the counter to women 18 and older that gradually loses efficacy after intercourse and can be taken at latest three days after sex.

WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing

A team of scientists from Lawrence Berkeley National Laboratory and the Scripps Research Institute has determined the crystal structure and molecular mechanisms of a key part of WRN, a protein that protects humans from premature aging and cancer.

Cadence Pharmaceuticals' IV acetaminophen NDA receives FDA Complete Response letter

Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for intravenous (IV) acetaminophen.

Slow caress or stroke may play part in creating, sustaining positive sense of self

A loving touch, characterized by a slow caress or stroke - often an instinctive gesture from a mother to a child or between partners in romantic relationships - may increase the brain's ability to construct a sense of body ownership and, in turn, play a part in creating and sustaining a healthy sense of self.

Read more News

› Verified 3 days ago



Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.